AUB ScholarWorks

Diabetes supersedes dobutamine stress echocardiography in predicting cardiac events in female patients

Show simple item record

dc.contributor.author Isma'eel H.
dc.contributor.author Shamseddeen W.
dc.contributor.author El Khoury M.
dc.contributor.author Dimassi A.
dc.contributor.author Nasrallah A.
dc.contributor.author Arnaout M.S.
dc.contributor.editor
dc.date 2010
dc.date.accessioned 2017-10-05T15:39:36Z
dc.date.available 2017-10-05T15:39:36Z
dc.date.issued 2010
dc.identifier
dc.identifier.isbn
dc.identifier.issn 03906663
dc.identifier.uri http://hdl.handle.net/10938/16980
dc.description.abstract Background: The many available choices for testing for coronary artery disease (CAD) brought about several questions regarding suitability of certain tests for different groups of patients and the prognostic value of obtained results in predicting events and mortality. The aim of this study is to describe the prognostic value of dobutamine stress echocardiography (DSE) results in predicting cardiac events and mortality in ≥ 60-year-old females. Methods: 49 women (≥ 60 years old) who were referred for DSE were included in the study. Data including CAD risk factors, and results of tests and a follow-up of events (MI, unstable angina, progression of CHF) and death. Results: Eleven patients were considered to have a positive DSE result. There was no difference between DSE (+) and DSE (-) patients in cardiac events and cardiac death. However when interventions were included to events, analysis showed DSE (+) to have more overall events. Non-cardiac deaths and all deaths were 11 and 8 times more common among DSE (+) patients compared with DSE (-) patients p 0.01. Multivariable logistic regression showed that diabetics and DSE (+) patients were 32 (p = 0.01) and 23 (p = 0.02) times more likely to have an event compared with non-diabetics and DSE (-) patients, respectively. Conclusion: DSE is a safe procedure to be used in ≥ 60-year-old female patients and can provide informative prognostic information regarding all-cause deaths and cardiac events (including interventions) over a 4-year period. In addition we find that diabetes is a strong predictor of events regardless of DSE result.
dc.format.extent
dc.format.extent Pages: (197-200)
dc.language English
dc.relation.ispartof Publication Name: Clinical and Experimental Obstetrics and Gynecology; Publication Year: 2010; Volume: 37; no. 3; Pages: (197-200);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Diabetes supersedes dobutamine stress echocardiography in predicting cardiac events in female patients
dc.type Article
dc.contributor.affiliation Isma'eel, H., Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
dc.contributor.affiliation Shamseddeen, W., Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
dc.contributor.affiliation El Khoury, M., Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
dc.contributor.affiliation Dimassi, A., Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
dc.contributor.affiliation Nasrallah, A., Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
dc.contributor.affiliation Arnaout, M.S., Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
dc.contributor.authorAddress Arnaout, M. S.; Division of Cardiology, Department of Internal Medicine, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon; email: sarnaout@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Cardiology;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision Cardiology
dc.contributor.authorEmail
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited
dc.description.citedCount
dc.description.citedTotWOSCount
dc.description.citedWOSCount
dc.format.extentCount 4
dc.identifier.articleNo
dc.identifier.coden CEOGA
dc.identifier.pubmedID 21077524
dc.identifier.scopusID 77958051515
dc.identifier.url
dc.publisher.address
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr
dc.relation.ispartOfIssue 3
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Clinical and Experimental Obstetrics and Gynecology
dc.relation.ispartofPubTitleAbbr Clin. Exp. Obstet. Gynecol.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 37
dc.source.ID
dc.type.publication Journal
dc.subject.otherAuthKeyword Coronary artery disease
dc.subject.otherAuthKeyword Diabetes
dc.subject.otherAuthKeyword Dobutamine stress echocardiography
dc.subject.otherChemCAS dobutamine, 34368-04-2, 52663-81-7
dc.subject.otherChemCAS Hydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subject.otherIndex dobutamine
dc.subject.otherIndex adult
dc.subject.otherIndex aged
dc.subject.otherIndex article
dc.subject.otherIndex cardiovascular risk
dc.subject.otherIndex clinical article
dc.subject.otherIndex controlled study
dc.subject.otherIndex coronary artery disease
dc.subject.otherIndex diabetes mellitus
dc.subject.otherIndex electrocardiography
dc.subject.otherIndex female
dc.subject.otherIndex follow up
dc.subject.otherIndex heart death
dc.subject.otherIndex human
dc.subject.otherIndex mortality
dc.subject.otherIndex prediction
dc.subject.otherIndex stress echocardiography
dc.subject.otherIndex Aged
dc.subject.otherIndex Aged, 80 and over
dc.subject.otherIndex Angina, Unstable
dc.subject.otherIndex Angioplasty, Balloon, Coronary
dc.subject.otherIndex Coronary Artery Bypass
dc.subject.otherIndex Diabetes Mellitus
dc.subject.otherIndex Echocardiography, Stress
dc.subject.otherIndex Electrocardiography
dc.subject.otherIndex Female
dc.subject.otherIndex Follow-Up Studies
dc.subject.otherIndex Heart Failure
dc.subject.otherIndex Humans
dc.subject.otherIndex Hydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subject.otherIndex Hypertension
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Multivariate Analysis
dc.subject.otherIndex Myocardial Infarction
dc.subject.otherIndex Prognosis
dc.subject.otherKeywordPlus
dc.subject.otherWOS


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account